232 related articles for article (PubMed ID: 1586450)
1. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells.
Chambers AF; Colella R; Denhardt DT; Wilson SM
Mol Carcinog; 1992; 5(3):238-45. PubMed ID: 1586450
[TBL] [Abstract][Full Text] [Related]
2. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
Tournu C; Obled A; Roux MP; Deval C; Ferrara M; Béchet DM
Arch Biochem Biophys; 1998 Dec; 360(1):15-24. PubMed ID: 9826424
[TBL] [Abstract][Full Text] [Related]
3. Physical association of Ras and cathepsins B and L in the conditioned medium of v-Ha-ras-transformed NIH3T3 cells.
Hiwasa T; Kominami E
Biochem Biophys Res Commun; 1995 Nov; 216(3):828-34. PubMed ID: 7488200
[TBL] [Abstract][Full Text] [Related]
4. Cysteine endopeptidases and their inhibitors in malignant progression of rat embryo fibroblasts.
Sloane BF; Rozhin J; Moin K; Ziegler G; Fong D; Muschel RJ
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):589-94. PubMed ID: 1515088
[TBL] [Abstract][Full Text] [Related]
5. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells.
Colella R; Casey SF
Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846
[TBL] [Abstract][Full Text] [Related]
6. [Cathepsins L and B and their endogenous inhibitors in embryonal fibroblasts transformed by different genes].
Dilakian EA; Vinokurova SV; Zhurbitskaia VA; Komissarova EV; Topol' LZ; Kiselev FL; Solov'eva NI
Vopr Med Khim; 1998; 44(1):35-42. PubMed ID: 9575611
[TBL] [Abstract][Full Text] [Related]
7. Conditioned medium from ras oncogene-transformed NIH 3T3 cells induces bone resorption in vitro.
Krieger NS; Sukhatme VP; Bushinsky DA
J Bone Miner Res; 1990 Feb; 5(2):159-64. PubMed ID: 2180257
[TBL] [Abstract][Full Text] [Related]
8. Nuclear localization of procathepsin L/MEP in ras-transformed mouse fibroblasts.
Hiwasa T; Sakiyama S
Cancer Lett; 1996 Jan; 99(1):87-91. PubMed ID: 8564934
[TBL] [Abstract][Full Text] [Related]
9. Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts.
Denhardt DT; Greenberg AH; Egan SE; Hamilton RT; Wright JA
Oncogene; 1987; 2(1):55-9. PubMed ID: 3438085
[TBL] [Abstract][Full Text] [Related]
10. Different patterns of gene expression in ras-resistant and ras-sensitive cells.
Tuck AB; Wilson SM; Khokha R; Chambers AF
J Natl Cancer Inst; 1991 Apr; 83(7):485-91. PubMed ID: 1848638
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic enzymes at various stages of oncogenic transformation of rat fibroblasts. I. Aspartyl and cysteine proteinases.
Solovyeva NI; Balayevskaya TO; Dilakyan EA; Zakamaldina-Zama TA; Pozdnev VF; Topol LZ; Kisseljov FL
Int J Cancer; 1995 Feb; 60(4):495-500. PubMed ID: 7829263
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 and transforming growth factor-beta 1 control expression of cathepsins B and L in human lung epithelial cells.
Gerber A; Wille A; Welte T; Ansorge S; Bühling F
J Interferon Cytokine Res; 2001 Jan; 21(1):11-9. PubMed ID: 11177576
[TBL] [Abstract][Full Text] [Related]
13. Differences in targeting and secretion of cathepsins B and L by BALB/3T3 fibroblasts and Moloney murine sarcoma virus-transformed BALB/3T3 fibroblasts.
Achkar C; Gong QM; Frankfater A; Bajkowski AS
J Biol Chem; 1990 Aug; 265(23):13650-4. PubMed ID: 2166039
[TBL] [Abstract][Full Text] [Related]
14. Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor.
Lorenzo K; Ton P; Clark JL; Coulibaly S; Mach L
Cancer Res; 2000 Aug; 60(15):4070-6. PubMed ID: 10945612
[TBL] [Abstract][Full Text] [Related]
15. Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis.
Trabandt A; Aicher WK; Gay RE; Sukhatme VP; Nilson-Hamilton M; Hamilton RT; McGhee JR; Fassbender HG; Gay S
Matrix; 1990 Dec; 10(6):349-61. PubMed ID: 2084514
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cathepsin L-induced degradation of epidermal growth factor receptors by c-Ha-ras gene products.
Hiwasa T; Sakiyama S; Yokoyama S; Ha JM; Fujita J; Noguchi S; Bando Y; Kominami E; Katunuma N
Biochem Biophys Res Commun; 1988 Feb; 151(1):78-85. PubMed ID: 3279952
[TBL] [Abstract][Full Text] [Related]
17. Presence of activated ras correlates with increased cysteine proteinase activities in human colorectal carcinomas.
Kim K; Cai J; Shuja S; Kuo T; Murnane MJ
Int J Cancer; 1998 Aug; 79(4):324-33. PubMed ID: 9699522
[TBL] [Abstract][Full Text] [Related]
18. Expression of cathepsins B and L in human lung epithelial cells is regulated by cytokines.
Gerber A; Welte T; Ansorge S; Bühling F
Adv Exp Med Biol; 2000; 477():287-92. PubMed ID: 10849756
[TBL] [Abstract][Full Text] [Related]
19. The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation.
Afonso S; Romagnano L; Babiarz B
Development; 1997 Sep; 124(17):3415-25. PubMed ID: 9310336
[TBL] [Abstract][Full Text] [Related]
20. Cystatins and cathepsins in breast carcinoma.
Lah TT; Kokalj-Kunovar M; Drobnic-Kosorok M; Babnik J; Golouh R; Vrhovec I; Turk V
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):595-604. PubMed ID: 1515089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
